Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Targeting flavonoids on modulation of metabolic syndrome

Full text
Author(s):
Neri-Numa, Iramaia Angelica [1] ; Betim Cazarin, Cinthia Bau [2] ; Tasca Gois Ruiz, Ana Lucia [3] ; Paulino, Bruno Nicolau [4] ; Molina, Gustavo [5] ; Pastore, Glaucia Maria [1]
Total Authors: 6
Affiliation:
[1] Univ Estadual Campinas, Fac Food Engn, Dept Food Sci, Lab Bioflavours & Bioact Cpds, UNICAMP, BR-13083862 Campinas, SP - Brazil
[2] Univ Estadual Campinas, Dept Food & Nutr, Nutr & Metab Lab, UNICAMP, BR-13083862 Campinas, SP - Brazil
[3] Univ Estadual Campinas, Fac Pharmaceut Sci, UNICAMP, BR-13083871 Campinas, SP - Brazil
[4] Fed Univ Amazonas UFAM, Fac Pharmaceut Sci, BR-69080900 Manaus, Amazonas - Brazil
[5] Fed Univ Jequitinhonha & Mucuri Valleys UFVJM, Inst Sci & Technol, Diamantina, MG - Brazil
Total Affiliations: 5
Document type: Review article
Source: Journal of Functional Foods; v. 73, OCT 2020.
Web of Science Citations: 0
Abstract

Metabolic Syndrome (MetS) is a complex condition associated with cardiovascular risk factors and diabetes. The weight gain, especially the accumulation of central adipose tissue, may be the first leading cause of the MetS. It is important to highlight that the lifestyle choices considered as modifiable risk factors contribute to the increase in the incidence of the MetS in the population, such as sedentarism and food intake. There is evidence in the literature concerning the benefits associated with the Mediterranean diet, which is rich in polyphenols. Therefore, the flavonoids are a class of non-nutrient that can be extensively studied mainly to elucidate the mechanisms related to the action of these compounds in the modulation of the microbiota, DNA methylation and health improvement. Thus, this review summarized evidence linking flavonoid intake to obesity, insulin resistance, T2DM and cardiovascular diseases. (AU)

FAPESP's process: 15/50333-1 - COBRA: a novel compound discovery pipeline for rapid and cost-effective identification of bioactives with health beneficial effects in Brazilian crops
Grantee:Glaucia Maria Pastore
Support Opportunities: Research Projects - Thematic Grants